Immune Cell Therapy Shows Promise Against Deadly Blood Cancer: – WEDNESDAY, Sept priligy 30 . 2, 2015 – – An experimental therapy for chronic lymphocytic leukemia that runs on the patient’s own immune cells may cure some sufferers and prolong survival in others with the bloodstream cancer, researchers report. The process of fabricating the therapy, called CTL019, begins with a patient’s own T cells, which certainly are a type of white blood cell needed for an immune response. The cells are reprogrammed to hunt and kill tumor cells then. After chemotherapy the patient receives an infusion of the engineered cells newly, the researchers explained.